Aker BioMarine Future Growth
Future criteria checks 3/6
Aker BioMarine's revenue is forecast to decline at 6.7% per annum while its annual earnings are expected to grow at 101.5% per year. EPS is expected to grow by 101.3% per annum. Return on equity is forecast to be 8.4% in 3 years.
Key information
101.5%
Earnings growth rate
101.3%
EPS growth rate
| Food earnings growth | 32.4% |
| Revenue growth rate | -6.7% |
| Future return on equity | 8.4% |
| Analyst coverage | Low |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 08
Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors
Nov 05At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?
Aug 20Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking
Jul 19What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates
Jul 16There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Jul 11These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way
Jun 03There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues
Feb 15There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Nov 06Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)
Sep 06We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings
Nov 04Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability
Apr 13Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Feb 18Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven
Jan 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 271 | 20 | 23 | 33 | 2 |
| 12/31/2025 | 240 | 9 | 9 | 13 | 2 |
| 12/31/2024 | 254 | 1 | -18 | -3 | 2 |
| 9/30/2024 | 335 | 3 | 14 | 52 | N/A |
| 6/30/2024 | 338 | -11 | 26 | 69 | N/A |
| 3/31/2024 | 336 | -8 | 6 | 51 | N/A |
| 12/31/2023 | 335 | -9 | -2 | 47 | N/A |
| 9/30/2023 | 227 | -15 | -20 | 25 | N/A |
| 6/30/2023 | 242 | 0 | -41 | 5 | N/A |
| 3/31/2023 | 268 | 14 | -35 | 12 | N/A |
| 12/31/2022 | 277 | 10 | -31 | 15 | N/A |
| 9/30/2022 | 274 | 1 | -43 | -2 | N/A |
| 6/30/2022 | 268 | 10 | -27 | 9 | N/A |
| 3/31/2022 | 269 | -8 | -29 | 4 | N/A |
| 12/31/2021 | 262 | -8 | -78 | 3 | N/A |
| 9/30/2021 | 262 | 3 | -85 | -17 | N/A |
| 6/30/2021 | 270 | -8 | -139 | -63 | N/A |
| 3/31/2021 | 268 | -14 | -134 | -59 | N/A |
| 12/31/2020 | 289 | -5 | -75 | -51 | N/A |
| 9/30/2020 | 285 | -26 | -65 | -23 | N/A |
| 6/30/2020 | 284 | -28 | -12 | 19 | N/A |
| 3/31/2020 | 278 | -18 | -3 | 33 | N/A |
| 12/31/2019 | 246 | -24 | -115 | 12 | N/A |
| 12/31/2018 | 154 | -1 | -57 | 8 | N/A |
| 12/31/2017 | 126 | -18 | N/A | N/A | N/A |
| 9/30/2017 | 123 | -15 | N/A | N/A | N/A |
| 6/30/2017 | 122 | -11 | N/A | N/A | N/A |
| 3/31/2017 | 119 | -5 | N/A | N/A | N/A |
| 12/31/2016 | 117 | -2 | N/A | 21 | N/A |
| 9/30/2016 | 111 | -8 | N/A | N/A | N/A |
| 6/30/2016 | 110 | 0 | N/A | N/A | N/A |
| 3/31/2016 | 109 | -3 | N/A | N/A | N/A |
| 12/31/2015 | 105 | 1 | N/A | 18 | N/A |
| 9/30/2015 | 105 | -5 | N/A | N/A | N/A |
| 6/30/2015 | 103 | -14 | N/A | N/A | N/A |
| 3/31/2015 | 111 | -13 | N/A | N/A | N/A |
| 12/31/2014 | 112 | -17 | N/A | -11 | N/A |
| 9/30/2014 | 99 | -34 | N/A | N/A | N/A |
| 6/30/2014 | 109 | 44 | N/A | N/A | N/A |
| 3/31/2014 | 106 | 43 | N/A | N/A | N/A |
| 12/31/2013 | 109 | 47 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKBM's forecast earnings growth (101.5% per year) is above the savings rate (2.4%).
Earnings vs Market: AKBM's earnings (101.5% per year) are forecast to grow faster than the Norwegian market (9.3% per year).
High Growth Earnings: AKBM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AKBM's revenue is expected to decline over the next 3 years (-6.7% per year).
High Growth Revenue: AKBM's revenue is forecast to decline over the next 3 years (-6.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AKBM's Return on Equity is forecast to be low in 3 years time (8.4%).